Potential Licensees

Pharmaceutical Companies

A Big Pharmaceutical company or Consortium developing cannabis-based drugs as treatments for various ailments can lead to both significant revenue growth and positive societal impact. The evidence supporting this rational is robust and aligns with the increasing acceptance and potential benefits of cannabis-based therapies.

Firstly, the market potential for cannabis-based drugs is substantial and continuously growing. Studies have shown that there is a high demand for alternative treatment options, especially for ailments like PTSD, severe pain, multiple sclerosis, ALS, epileptic seizures, cancer, Alzheimer’s, and nausea, where traditional therapies may have limited efficacy or side effects. By developing innovative cannabis-based drugs for these conditions, a pharmaceutical company or Consortium can tap into a lucrative and expanding market, leading to substantial revenue growth.

Secondly, cannabis has demonstrated therapeutic potential in treating a wide range of medical conditions. Research has shown that cannabinoids, the active compounds found in cannabis, possess anti-inflammatory, analgesic, neuroprotective, and anti-tumor properties that can be beneficial in addressing various health issues. By exploring the medicinal properties of cannabis and developing targeted pharmaceutical formulations, companies can provide safe and effective treatment options for patients suffering from debilitating ailments.

Moreover, by investing in the research and development of cannabis-based drugs, a pharmaceutical company or Consortium can contribute to the advancement of medical science and improve patient outcomes. The introduction of novel cannabis-based therapies for conditions such as PTSD, chronic pain, neurological disorders, and cancer can offer new hope and relief to patients who may have exhausted traditional treatment options. Additionally, by conducting clinical trials and obtaining regulatory approvals for cannabis-based drugs, these companies can help legitimize the use of cannabis in medicine and destigmatize its therapeutic potential.

In conclusion, the evidence supporting the development of cannabis-based drugs for various medical conditions highlights the potential for both substantial revenue growth for a pharmaceutical company or Consortium and meaningful societal contributions. By harnessing the therapeutic properties of cannabis, these entities can provide innovative treatment options for patients in need, advance medical research, and positively impact public health outcomes. Investing in cannabis-based drug

development represents a promising opportunity to drive revenue growth while making a significant difference in the lives of individuals suffering from complex and challenging health conditions.

Given the myriad medical benefits of cannabis extracts and the enormous market size it is no wonder that Pharmaceutical Companies are aggressively investing into the medical cannabis industry. Due to the ability of the VCT vapor cartridges to consistently and safely deliver an exact dose of a prescribed formulation of cannabis extracts in vapor form, they will in time, receive FDA approval for use in clinical research into the medical value of cannabis extracts.

https://www.visualcapitalist.com/the-big-pharma-takeover-of-medical-cannabis

Tobacco Companies

Having an exclusive license to the Vapor Cartridge Technology is business critical for big tobacco companies like Philip Morris or Reynolds American due to the potential for market dominance, increased revenue, and strategic advantage in the rapidly evolving cannabis market. The evidence supporting this strategy is strong and aligns with market dynamics and consumer preferences.

Firstly, an exclusive license to Vapor Cartridge Technology can provide a significant competitive advantage by allowing a tobacco company to differentiate itself from competitors and establish a strong market position. Studies have shown that exclusive rights to innovative technologies can lead to higher market share, brand loyalty, and profitability. By being the sole licensee of this technology, Tobacco companies like Philip Morris or Reynolds American can solidify their position as industry leaders in the cannabis market.

Secondly, the evidence suggests that the market for cannabis extracts in vapor form is expanding rapidly, driven by consumer demand for alternative and potentially safer ways to consume cannabis extracts. By holding an exclusive license to Vapor Cartridge Technology, a tobacco company can capitalize on this growing market and offer a unique and innovative product that meets consumer preferences for convenience and harm reduction.

Moreover, an exclusive license to Vapor Cartridge Technology can provide a revenue stream through licensing agreements with other companies interested in utilizing this technology. Studies have shown that licensing revenue can contribute significantly to a company’s bottom line and enhance overall financial performance. By granting exclusive licenses to other companies, Philip Morris or Reynolds American, for example, could further leverage the value of the technology and create additional revenue opportunities.

In conclusion, the evidence supporting the business criticality of having an exclusive license to Vapor Cartridge Technology is compelling for big tobacco companies like Philip Morris or Reynolds American. By securing exclusive rights to this innovative technology, these companies can establish market dominance, drive revenue growth, and gain a strategic advantage in the competitive cannabis extracts delivery market. Holding an exclusive license to Vapor Cartridge Technology can position a tobacco company for success and leadership in the evolving landscape of cannabis extracts consumption.

Producers of adult beverages

Being the first to commercialize Vapor Cartridge Technology is strategically critical for big alcoholic beverage companies like Coors or Budweiser due to the potential for market leadership, competitive advantage, and brand differentiation. The evidence supporting this strategy is robust and aligns with consumer trends and industry dynamics.

Firstly, being the first mover in introducing cannabis extracts in a convenient VCT vapor cartridge form can establish a strong market position and brand recognition. Studies have shown that companies that innovate and introduce new technologies ahead of competitors often enjoy higher market share and brand loyalty. By pioneering Vapor Cartridge Technology, adult beverage companies can differentiate themselves as industry leaders and innovators in the alcoholic beverage market.

Secondly, the early adoption of this technology can help these companies capture the attention and loyalty of early adopters and trendsetters. Consumers are increasingly seeking unique and novel psychological experiences, and VCT Vapor cartridges offer a distinctive and innovative option that can resonate with this consumer segment. By being the first to market with Vapor Cartridge Technology, beverage companies like Coors or Budweiser can attract and retain these valuable consumer groups.

In conclusion, the evidence supporting the business criticality of being the first to commercialize Vapor Cartridge Technology is strong for big alcoholic beverage companies. By taking the lead in introducing this innovative technology, these companies can establish themselves as market leaders, attract early adopters, and capitalize on the growing demand for unique and experiential options. Being the first mover in commercializing Vapor Cartridge Technology can provide a significant competitive advantage and drive success in a rapidly evolving market.

https://www.theverge.com/2019/7/30/18639829/weed-beer-drinkable-marijuana-cannabis-drinks-alcohol

Big Cannabis Cultivators

Big Cannabis cultivators like Curaleaf, Canopy Growth Corp, and the Cronos Group should prioritize utilizing Vapor Cartridge Technology to enhance the value of their crop for several reasons.

Firstly, Vapor Cartridge Technology offers a more efficient and effective method of consuming cannabis compared to traditional smoking methods. This is particularly appealing to consumers who are concerned about the health risks associated with smoking. By providing a healthier consumption option, big cultivators can attract a larger segment of the market and increase their overall sales.

Secondly, Vapor Cartridge Technology allows for better control over dosage and potency, providing a more consistent and reliable experience for consumers. This can help build trust and loyalty among customers, ultimately leading to repeat business and increased brand reputation.

Furthermore, utilizing Vapor Cartridge Technology can help big cultivators differentiate themselves in a crowded market. By offering a higher quality product with enhanced features, they can position themselves as leaders in the industry and command premium prices for their products.

Lastly, Vapor Cartridge Technology can also help reduce waste and increase efficiency in the production process. By using VCT vapor cartridges, cultivators can ensure that every “drop” of their valuable crop is utilized, maximizing the return on their investment.

In conclusion, big Cannabis cultivators have a lot to gain by incorporating Vapor Cartridge Technology into their operations. From attracting new customers to improving product quality and efficiency, the benefits of this technology are clear. By embracing innovation and staying ahead of the curve, companies like Curaleaf, Canopy Growth Corp, and the Cronos Group can secure their position as industry leaders and drive long-term success.

And one more thing: The major issue facing legal cannabis growers is the black market.

The reason for the strength of the black market is straightforward. Black marketers are selling the same retail product (dried flower heads) at a much lower price. The technical presentation in the Science section demonstrated that the Vapor Cartridge Technology will result in product that, even after taxation, is lower cost than the black market; and it is counterfeit-proof! And will be very convenient to purchase and use. The value of the cash crop will increase as a source for processing into a vapor cartridge.

Manufacturers of extraction & processing equipment

For a manufacturer of cannabis extraction and processing equipment, offering extraction equipment based on Vapor Cartridge Technology presents a smart business opportunity for several reasons.

Firstly, Vapor Cartridge Technology will rapidly gain popularity in the cannabis industry due to its efficiency, convenience, and health benefits. By aligning their product offerings with this trend, manufacturers can tap into a growing market segment and increase their revenue potential.

Secondly, extraction equipment based on Vapor Cartridge Technology can provide manufacturers with a competitive edge in the industry. As more cannabis cultivators adopt this technology to enhance the value of their crop, manufacturers that offer compatible extraction equipment can position themselves as industry leaders and attract a larger customer base.

Additionally, Vapor Cartridge Technology offers a more precise and controlled method of extracting cannabinoids from the plant material, leading to higher-quality end products. By providing equipment that enables cultivators to produce superior extracts, manufacturers can help their customers create premium products that stand out in the market.

Moreover, offering extraction equipment based on Vapor Cartridge Technology can also help manufacturers diversify their product portfolio and expand their customer base. As the demand for cannabis extracts continues to grow, manufacturers that provide innovative and efficient extraction solutions will be well-positioned to capitalize on this trend.

In conclusion, for a manufacturer of cannabis extraction and processing equipment, incorporating Vapor Cartridge Technology into their product offerings makes good business sense. By leveraging this technology to meet the evolving needs of cannabis cultivators and processors, manufacturers can drive sales, gain a competitive advantage, and ultimately achieve long-term success in the industry.

These companies are well positioned to significantly benefit from a license to manufacture and sell products utilizing the Vapor Cartridge Technology (VCT). Manufacturers of extraction & processing equipment already have an existing customer base who are in the business of extracting cannabis oils to be turned into retail products like tinctures for oral consumption, or oils for vaping devices. This customer base would highly value a process that would enable them to, very cost effectively, convert flower directly into retail products (i.e., vapor cartridges). Also, the market for extraction equipment is very competitive. By way of example below are a few companies in this crowded and competitive industry. An extraction equipment manufacturer would greatly benefit financially from having an exclusive legal monopoly, by way of patent protection, on a far better method for delivering cannabis vapors to the user’s pulmonary tract. As described under the “Competitive Analysis” tab, VCT Vapor cartridges will most likely replace vaporizers that use cannabis extracts as a source for producing cannabis vapors.

Root Science

https://www.rootsciences.com/#:~:text=The%20company%20leading%20the%20trend,distiller%20for%20the%20cannabis%20industry

Agrify

Savvy cannabis Entrepreneurs on the West Coast

The whole west coast (Washington State, Oregon, California) is the perfect location to launch a new business based on the “Wine Business Model”. There are ample sources of supply, a large customer base and friendly state governments. There are also ample technical and manufacturing capabilities to commercialize the Vapor Cartridge Technology.